133 related articles for article (PubMed ID: 19639558)
21. Impaired Ribosome Biogenesis and Skeletal Muscle Growth in a Murine Model of Inflammatory Bowel Disease.
Figueiredo VC; Markworth JF; Durainayagam BR; Pileggi CA; Roy NC; Barnett MP; Cameron-Smith D
Inflamm Bowel Dis; 2016 Feb; 22(2):268-78. PubMed ID: 26588088
[TBL] [Abstract][Full Text] [Related]
22. Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.
Jurisic G; Sundberg JP; Bleich A; Leiter EH; Broman KW; Buechler G; Alley L; Vestweber D; Detmar M
Genes Immun; 2010 Apr; 11(3):219-31. PubMed ID: 20220769
[TBL] [Abstract][Full Text] [Related]
23. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.
Punit S; Dubé PE; Liu CY; Girish N; Washington MK; Polk DB
Gastroenterology; 2015 Oct; 149(4):993-1005.e2. PubMed ID: 26072395
[TBL] [Abstract][Full Text] [Related]
24. Gene expression patterns in experimental colitis in IL-10-deficient mice.
Hansen JJ; Holt L; Sartor RB
Inflamm Bowel Dis; 2009 Jun; 15(6):890-9. PubMed ID: 19133689
[TBL] [Abstract][Full Text] [Related]
25. Lactobacillus plantarum LP‑Onlly alters the gut flora and attenuates colitis by inducing microbiome alteration in interleukin‑10 knockout mice.
Chen H; Xia Y; Zhu S; Yang J; Yao J; Di J; Liang Y; Gao R; Wu W; Yang Y; Shi C; Hu D; Qin H; Wang Z
Mol Med Rep; 2017 Nov; 16(5):5979-5985. PubMed ID: 28849048
[TBL] [Abstract][Full Text] [Related]
26. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
28. Solute carriers (SLC) in inflammatory bowel disease: a potential target of probiotics?
Kotka M; Lieden A; Pettersson S; Trinchieri V; Masci A; D'Amato M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S133-5. PubMed ID: 18806705
[TBL] [Abstract][Full Text] [Related]
29. Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species.
Regmi SC; Park SY; Ku SK; Kim JA
Free Radic Biol Med; 2014 Apr; 69():377-89. PubMed ID: 24524998
[TBL] [Abstract][Full Text] [Related]
30. Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men.
Burton KJ; Rosikiewicz M; Pimentel G; Bütikofer U; von Ah U; Voirol MJ; Croxatto A; Aeby S; Drai J; McTernan PG; Greub G; Pralong FP; Vergères G; Vionnet N
Br J Nutr; 2017 May; 117(9):1312-1322. PubMed ID: 28558854
[TBL] [Abstract][Full Text] [Related]
31. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells.
Caballero-Franco C; Keller K; De Simone C; Chadee K
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G315-22. PubMed ID: 16973917
[TBL] [Abstract][Full Text] [Related]
32. Multistep mechanism of probiotic bacterium, the effect on innate immune system.
Amit-Romach E; Uni Z; Reifen R
Mol Nutr Food Res; 2010 Feb; 54(2):277-84. PubMed ID: 19998380
[TBL] [Abstract][Full Text] [Related]
33. Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses.
Mastrangeli G; Corinti S; Butteroni C; Afferni C; Bonura A; Boirivant M; Colombo P; Di Felice G
Int Arch Allergy Immunol; 2009; 150(2):133-43. PubMed ID: 19439979
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice.
Froicu M; Zhu Y; Cantorna MT
Immunology; 2006 Mar; 117(3):310-8. PubMed ID: 16476050
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
Vanderpool C; Yan F; Polk DB
Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
[TBL] [Abstract][Full Text] [Related]
36. The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an
Aghamohammad S; Sepehr A; Miri ST; Najafi S; Pourshafie MR; Rohani M
Can J Gastroenterol Hepatol; 2022; 2022():2045572. PubMed ID: 36397951
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3.
Talero E; Bolivar S; Ávila-Román J; Alcaide A; Fiorucci S; Motilva V
Inflamm Bowel Dis; 2015 May; 21(5):1027-37. PubMed ID: 25793324
[TBL] [Abstract][Full Text] [Related]
38. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses.
de Buhr MF; Mähler M; Geffers R; Hansen W; Westendorf AM; Lauber J; Buer J; Schlegelberger B; Hedrich HJ; Bleich A
Physiol Genomics; 2006 May; 25(3):426-34. PubMed ID: 16705022
[TBL] [Abstract][Full Text] [Related]
39. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
40. Modulation of human dendritic cell phenotype and function by probiotic bacteria.
Hart AL; Lammers K; Brigidi P; Vitali B; Rizzello F; Gionchetti P; Campieri M; Kamm MA; Knight SC; Stagg AJ
Gut; 2004 Nov; 53(11):1602-9. PubMed ID: 15479680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
